• 한국환경보건학회지
• /
• 제44권2호
• /
• pp.196-203
• /
• 2018

Objectives: The purpose of this study was to assess environmental risk on the emerging contaminants of concern, such as ivermetin, parziquantel, tamiflu and triclosan. Furthermore, we tried to provide a more efficient management practice and a basis for future studies of risk assessment on those substances. Methods: Predicted no effect concentration (PNEC) and predicted environmental concentration (PEC) were determined through modeling and literature reviews. Environmental risk assessment was evaluated by calculating HQ (hazard quotient) by a comparison of PEC (or measured environmental concentration (MEC)) and PNEC. Results: HQ value of tamiflu calculated from MEC was 1.9E-03. For ivermectin and triclosan, the HQ values were not available because these were not detected in the aquatic environment. The toxicity of ivermectin and triclosan showed a very low value, indicating a high level of HQ. However, praziquantel can be categorized into the material that do not require management since they have less than HQ 1. Conclusion: Based on the results of the initial risk assessment, it is assumed that the ivermectin and triclosan have potential to cause direct adverse effects on the aquatic environment. To conduct an accurate environmental risk assessment, the further study on PEC estimation of such contaminants should be actively carried out.

• BMB Reports
• /
• 제53권11호
• /
• pp.565-575
• /
• 2020

Gene therapy is emerging as a treatment option for inherited genetic diseases. The success of this treatment approach greatly depends upon gene delivery vectors. Researchers have attempted to harness the potential of viral vectors for gene therapy applications over many decades. Among the viral vectors available, gutless adenovirus (GLAd) has been recognized as one of the most promising vectors for in vivo gene delivery. GLAd is constructed by deleting all the viral genes from an adenovirus. Owing to this structural feature, the production of GLAd requires a helper that supplies viral proteins in trans. Conventionally, the helper is an adenovirus. Although the helper adenovirus efficiently provides helper functions, it remains as an unavoidable contaminant and also generates replication-competent adenovirus (RCA) during the production of GLAd. These two undesirable contaminants have raised safety concerns and hindered the clinical applications of GLAd. Recently, we developed helper virus-free gutless adenovirus (HF-GLAd), a new version of GLAd, which is produced by a helper plasmid instead of a helper adenovirus. Utilization of this helper plasmid eliminated the helper adenovirus and RCA contamination in the production of GLAd. HF-GLAd, devoid of helper adenovirus and RCA contaminants, will facilitate its clinical applications. In this review, we discuss the characteristics of adenoviruses, the evolution and production of adenoviral vectors, and the unique features of HF-GLAd as a new platform for gene therapy. Furthermore, we highlight the potential applications of HF-GLAd as a gene delivery vector for the treatment of various inherited genetic diseases.

• 청정기술
• /
• 제24권4호
• /
• pp.293-300
• /
• 2018

설파메톡사졸(sulfamethoxazole, SMX)은 박테리아 치료를 위해 사람과 동물에게 널리 사용되어 온 설파아미드계열의 합성 항생제이다. 이들 대부분은 난분해성 물질로서 분해되지 않고 환경생태계에 노출되어 심각한 환경문제를 일으키게 된다. 본 연구에서는 난분해성 SMX를 분해하기 위하여 $Cu/Al_2O_3$ 촉매를 이용한 촉매습식과산화(catalytic wet peroxide oxidation, CWPO) 공정을 수행하였고, SMX를 완전히 분해하기 위한 최적의 온도, 촉매 주입량, 과산화수소($H_2O_2$)의 농도 등을 조사하였다. 1기압, $40^{\circ}C$에서 $H_2O_2$ 0.79 mM과 6 g의 10 wt% $Cu/Al_2O_3$ 촉매를 사용하여 20분 이내에 SMX가 완전히 분해되는 것으로 관찰되었다. 그러나 SMX는 완전히 무기화 되지 못하고, 중간생성물인 hydroylated-SMX, sulfanilic acid, 4-aminobenzenesulfinic acid, nitrobenzene을 거쳐 유기산으로 분해된 후 최종적으로 무기화 되었다. 이들 중간생성물의 거동을 파악하여 SMX의 분해 반응경로를 예측하였고 불균일 촉매의 내구성을 알아보기 위하여 10 wt% $Cu/Al_2O_3$ 촉매를 연속적으로 재사용 하여 SMX 분해율을 조사하였다. SMX의 분해율은 촉매를 5회 이상 재 사용하였을 때 다소 낮아졌지만 촉매의 활성도는 전반적으로 매우 안정적이었다.